To further determine whether GSS inhibits sepsis‐induced lung vascular EC apoptosis in vivo, we used immunoblot analysis and immunofluorescence microscopy to determine the changes in lung BCL‐2 expression, caspase‐3 activation and lung vascular EC apoptosis. This evidence concerns the gene BCL2 and Sepsis.